Shugarman, Alan E.
November 2000
Joe Weider's Muscle & Fitness;Nov2000, Vol. 61 Issue 11, p192
Focuses on the ruling of the United States Drug Enforcement Administration to ban prohormone-based dietary supplements and androstenedione. Criteria used by the government agency; Reason for the decision to prohibit the use of the substance; Properties of the substance; Its effect to muscles; Research made about the substance. INSET: Research Briefs.


Related Articles

  • Beefing up Rx security. Blank, Dennis // Modern Physician;May2002, Vol. 6 Issue 5, p24 

    Reports that the U.S. Department of Justice's Drug Enforcement Administration will issue proposed regulations requiring that doctors and pharmacists use digital signatures and biometric scanners when transmitting electronic prescriptions for Class II drugs. States that are actively involve in...

  • Border crossers may face limits on CSA Rxs.  // Drug Topics;5/19/97, Vol. 141 Issue 10, p7 

    Reports that the US Drug Enforcement Administration wants to put limitations on the amount of Controlled Substances Act Rx medication that people entering the United States can bring for personal medical use. Aim of proposed policy change.

  • DEA clarifies amount of narcotics one can bring in.  // Drug Topics;10/6/2003, Vol. 147 Issue 19, p7 

    Reports that the U.S. Drug Enforcement Agency proposed to limit to 50 dosage units, the total amount of controlled substances a U.S. resident may bring into the country for personal medical use without a prescription when returning from travel abroad.

  • DEA limits personal Rx importation.  // Drug Topics;9/27/2004, Vol. 148 Issue 18, p8 

    This article states that the United States Drug Enforcement Administration plans to limit the personal importation of controlled substances for legitimate medical use.

  • Wedgewood can resume drug dispensing alter 8-year tussle with DEA.  // DVM: The Newsmagazine of Veterinary Medicine;Jul2010, Vol. 41 Issue 7, p34 

    The article reports on the eight-year disagreement of Wedgewood Pharmacy with the U.S. Department of Justice, Drug Enforcement Administration (DEA) over the interpretation of controlled substance dispensing rules.

  • DEA proposes new rules on loss of controlled substances. Chi, Judy // Drug Topics;8/04/2003, Vol. 147 Issue 15, p64 

    Reports on the U.S. Drug Enforcement Administration's (DEA) proposed rules on loss of controlled substances (CS). Factors that can help pharmacies determine reporting an episode to the DEA is warranted; Guidelines on CS breakage or spillage.

  • DEA issues final rule on central fill pharmacies. Levy, Sandra // Drug Topics;8/18/2003, Vol. 147 Issue 16, p50 

    Reports on the U.S. Drug Enforcement Administration's issuance of final rule that defines central fill activities and permits central fill pharmacies to prepare controlled-substance prescription on behalf of retail pharmacies. Provisions of the rule; Impact on the pharmaceutical industry.

  • DEA trip script and enforcement program appears dead.  // Drug Topics;5/8/95, Vol. 139 Issue 9, p20 

    Reports that the Drug Enforcement Administration has given up plans to seek authority to impose stricter pharmacy reporting regulations and expand its enforcement powers over controlled substances.

  • Oral Rxs for Schedule II controlled substances. Fitzgerald Jr., Walter L. // Drug Topics;3/18/96, Vol. 140 Issue 6, p56 

    Discusses information about the emergency dispensing exception to the United States Drug Enforcement Administration's (DEA) regulations on prescriptions for Schedule II controlled substances. Definition of emergency; Quantity dispensed; Unknown prescriber; Record-keeping; Points to remember.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics